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Abstract
Mutations in adaptor protein complex-4 (AP-4) genes have first been identified in
2009, causing a phenotype termed as AP-4 deficiency syndrome. Since then several
patients with overlapping phenotypes, comprised of intellectual disability (ID) and
spastic tetraplegia have been reported. To delineate the genotype-phenotype corre-
lation of the AP-4 deficiency syndrome, we add the data from 30 affected individuals
from 12 out of 640 Iranian families with ID in whom we detected disease-causing
variants in AP-4 complex subunits, using next-generation sequencing. Furthermore,
by comparing genotype-phenotype findings of those affected individuals with previ-
ously reported patients, we further refine the genotype-phenotype correlation in this
syndrome. The most frequent reported clinical findings in the 101 cases consist of ID
and/or global developmental delay (97%), speech disorders (92.1%), inability to walk
(90.1%), spasticity (77.2%), and microcephaly (75.2%). Spastic tetraplegia has been
reported in 72.3% of the investigated patients. The major brain imaging findings are
abnormal corpus callosum morphology (63.4%) followed by ventriculomegaly
(44.5%). Our result might suggest the AP-4 deficiency syndrome as a major differen-
tial diagnostic for unknown hereditary neurodegenerative disorders.
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1 | INTRODUCTION
The adaptor protein complex-4 (AP-4) complex, one of the five vari-
ous adaptor protein complexes,1 is localized on the Trans-Golgi Net-
work (TGN), involved in the transport of cargoes from the TGN to
endosomes2 and autophagosomal structures.3 This complex consists
of two large chains (β-4 and ε-4), a medium-chain (μ-4) and a small
chain (σ-4), which are encoded by AP4B1, AP4E1, AP4M1 and AP4S1,
respectively.4 Supporting evidence has shown that the AP-4 complex
contributes to normal development and function of the brain.2 Varia-
tions in genes encoding these complexes, were first reported by Ver-
kerk et al in 2009,5 and then described as a distinct syndrome, AP-4
deficiency syndrome, by Moreno-De-Luca et al in 2011.6 This syn-
drome has been characterized as a subset of hereditary spastic para-
plegia, which is very heterogeneous and mainly caused by
neurological dysfunctions, such as ID and corpus callosum
abnormalities.5,7,8
Here we present our findings on 30 affected individuals from
12 Iranian families with disease-causing variants in various subunits of
AP-4 complex genes. In order to further delineate the genotype-
phenotype correlation of the AP-4 deficiency syndrome, we also com-
pared our clinical and molecular findings with previously reported
patients in the literature published till mid-March 2020.
2 | MATERIALS AND METHODS
We selected 12 families from our large cohort of ID patients, in whom
disease-causing variants in various subunits of the AP-4 complex have
been identified. Our cohort consists of 640 Iranian families, mostly
consanguineous with ≥2 affected individuals, who were primarily
referred by physicians or clinical geneticists from all over the country
to the Genetics Research Center (GRC), between 2007 and 2018 for
ID molecular diagnosis. This study was approved by the Ethics Com-
mittee at the University of Social Welfare and Rehabilitation Sciences
(USWR), Tehran, Iran, and written informed consent was obtained
from the legal guardian of patients (Methods in Appendix S1).
3 | RESULTS
We identified nine different disease-causing variants in AP4M1,
AP4B1, AP4S1 and AP4E1 in 50%, 25%, 16.7% and 8.3% of our 12 Ira-
nian families, respectively (Table S1).
The majority of those families had reported consanguineous mar-
riage (11/12); although one family had a nonconsanguineous condi-
tion, both parents had come from the same village (Figure S2-A and
Table S1). All disease-causing variants in AP-4 complex subunits were
inherited in a homozygous status. Eighteen out of the 30 patients
(60%) were males and the average age of the affected individuals at
the last examination was 16.5-year. The age of onset was at early
infancy except for three patients, which manifested later in infancy,
varied from 2 to 3-year (M-254) (Table S1).
Short stature, ranging from −2.6SD to −7.3SD, and microcephaly,
varying from −2.1SD to −7.1SD were noticed in 86.7% and 90% of
the patients, respectively. Developmental disability (DD) or ID were
reported in all patients; of whom 96.7% were severely intellectually
disabled. Severely impaired speech was noted in all patients. Seizures
were reported in 86.7% of the patients, with seizure manifestation in
all patients harboring a variant in AP4B1 or AP4S1. Although all of the
patients with disease-causing variants in AP4M1, AP4B1 and AP4S1
developed infantile hypotonia, this phenotype was absent in patients
with the AP4E1 variant. All patients manifested spastic tetraplegia and
all had lost the ability to walk throughout their life. Spasticity and
hypertonia were also universal presentations in all patients. Dysmor-
phic features were noted in all patients; of which bitemporal
narrowing and broad nasal ridge were reported as the most common
features. Noteworthy, strabismus was universally observed in the
patients. Brain imaging findings of the patients are presented
(in supplement), if available. Enlarged sylvian cistern, thin corpus cal-
losum, and ventriculomegaly were reported with higher frequency
than other findings in brain images.
Clinical descriptions of the patients, photographs, pedigrees and
MRIs are shown in Tables S1 and S2 and Figure S2A,B,C.
Seven patients from three unrelated Iranian families (M-004, M-
8800140 and M-8800050), living in different geographic locations
carry the recurrent AP4M1 variant p.(Glu193Lys). Our previous inves-
tigation showed that this variant is located in the haplotype region
with a size of ~2.6 Mb shared in the affected individuals (Table S1).9
The AP4B1 variant, p.(Thr387Argfs*30) identified in family M-
8900295 is also recurrent as it has previously been reported by
Abdollahpour et al (2015)10 and Szczałuba et al (2020)11 in non-
consanguineous families diagnosed with ID and spastic tetraplegia
and hereditary spastic paraplegia type 47 (SPG47), respectively
(Table S1).
We also report five cases from two unrelated Iranian consanguin-
eous families with ID, carrying a homozygous stop-gain variant, p.
(Arg97*), in AP4S1. This variant with another frameshift variant, p.
(Gln46Profs*9), in trans status has been reported by Hardies et al,12
causing mild fever-sensitive seizures, DD and spastic paraplegia in a
Caucasian nonconsanguineous family (Table S1).
Iranian patients were quite different from cases in the literature,
particularly in terms of facial hypotonia, ability to walk and brain
abnormalities (Tables S1 and S2). We summarized all clinic-radiological
data of 101 cases in Table 1A-F.
Overall, short stature, abnormality of the face, obesity,
stereotypic laughter, inability to walk, and cerebellar and cerebral
abnormalities were seen more frequently in patients with AP4E1
disease-causing variants than in patients with variants in other AP-4
complex subunits. In cases with AP4M1 variants, abnormalities of the
musculature, limbs and joint were more frequently noticed than in
patients with variants in other AP-4 complex subunits. Speech disor-
der and upper motor neuron dysfunction appeared in all patients with
AP4M1 or AP4E1 variants. Furthermore, inability to walk was also
more frequently documented in these cases. Aggressive behavior was
not reported in patients with the AP4E1 variant; however, stereotypic
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TABLE 1 Categorizations of clinic-radiological data of 101 cases (including unavailable data) with AP-4 complex subunits in percentage
Phenotype category AP4M1 AP4B1 AP4S1 AP4E1
A Abnormality of head and growth
Short stature 45.4 50 60 66.7
Microcephaly 75.7 72.7 80 77.8
Abnormality of the face 81.8 61.4 86.7 100
Strabismus 60.6 25 53.3 33.3
Obesity 0 4.5 0 33.3
B Central nervous system featuresa
Neurodevelopmental delay 100 93.2 100 100
Seizure 69.7 79.5 60 55.5
Speech disorder 100 86.4 86.7 100
Inability to walk 97 84.1 86.7 100
Upper motor neuron dysfunction 100 79.5 93.3 100
Abnormal reflex 75.7 70.4 60 55.5
Pseudobulbar sign 30.3 4.5 0 22.2
Drooling 54.5 25 53.3 44.4
C Abnormality of the musculatureb
Abnormality of the musculature 100 75 73.3 66.7
Abnormality of limbs 69.7 40.9 53.3 22.2
Abnormality of joint mobility 63.6 40.9 53.3 55.5
D Behavioral abnormalities
Aggressive behavior 18.2 6.8 0 0
Shyness 21.2 11.4 33.3 22.2
Stereotypic laughter 63.6 34.1 53.3 88.9
E Brain MRI abnormalities
Ventriculomegaly 66.7 34.1 20 55.5
Hypoplasia of the corpus callosum 66.7 72.7 40 44.4
White matter abnormalities 24.2 40.9 26.7 11.1
Enlarged sylvian cistern 36.4 20.4 33.3 44.4
Abnormal morphology of the hippocampus 42.4 11.4 0 44.4
Abnormality of the pons 9.1 2.3 0 0
Gliosis 3 0 0 0
Cerebral degeneration 3 11.4 0 33.3
Aplasia/Hypoplasia of the cerebellum 33.3 2.3 0 44.4
F Facial dysmorphisms in details
Coarse facial features 33.3 2.3 20 44.4
Long & narrow face 0 6.8 0 22.2
Bitemporal narrowing 45.4 22.7 33.3 55.5
Broad nasal ridge 48.5 29.5 33.3 55.5
Bulbous nose 51.5 27.3 66.7 44.4
Long nose 0 0 0 22.2
Broad nasal bridge 36.4 25.0 46.7 33.3
Prominent nose 18.2 4.5 40 44.4
Short philtrum 33.3 15.9 46.7 22.2
Everted upper lip vermilion 45.4 22.7 33.3 22.2
Full lips 0 0 13.3 0
Wide mouth 57.6 22.7 66.7 44.4
(Continues)
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laughter was more frequent in these cases than in cases with variants
in other AP4-subunits. Although ventriculomegaly was as prevalent as
corpus callosum abnormality in patients with AP4M1 variants, for
those with AP4E1 alterations, ventriculomegaly was documented
more frequently than the corpus callosum abnormality. In cases with
AP4B1 or AP4S1 variants, abnormality of the corpus callosum was
more common reported than ventriculomegaly. Cerebellar and cere-
bral abnormalities were not present in any case with AP4S1 variation.
Moreover, through data investigation in the pfam database
(https://pfam.xfam.org/), we depicted the location of each identified
disease-causing variant in the corresponding AP-4 complex subunits,
in the schematic illustration of domain structures in Figure S1.
Totally, we combined 12, 23, 6 and 4 variants in AP4M1, AP4B1,
AP4S1 and AP4E1, respectively.
4 | DISCUSSION
Since the AP-4 deficiency syndrome was first reported by Verkerk
et al5 in 2009, and homozygous AP4M1 variants were identified,
causing ID and tetraplegic cerebral palsy (SPG50; OMIM#
612936), many other patients with overlapping clinical pheno-
types have been reported, in whom the diseases resulted from
pathogenic variants in AP-4 subunits such as AP4E1 (SPG51;
OMIM#613744), AP4B1 (SPG47; OMIM#614066), and AP4S1
(SPG52; OMIM#614067).6,8,12-14 Here, we discuss the
phenotype–genotype correlation of 101 patients in the spectrum
of AP-4 related diseases.
The highest number of inherited disease-causing variants among
various subunits of the AP-4 complex in Iranian cases belongs to
AP4M1, followed by AP4B1, AP4S1 and AP4E1, respectively; however,
combining our data with data from non-Iranian patients places AP4B1
at the top. Eight out of 44 cases (18.2%) with the AP4B1 variants were
from Iran (Tables S1 and S2).
Thirty-two out of the 57 families (56.1%) discussed in this paper,
reported consanguineous marriages; of which 34.4% were Iranian. Bi-
allelic variants in homozygous state were the most common alter-
ations in AP-4 deficiency syndrome (Table S1 and Figure S1).
4.1 | Major clinical findings in AP-4 deficiency
syndrome
Our findings and those reported by others combined suggest that the
major clinical findings with nearly two-third prevalence in AP-4 defi-
ciency are as follows (Table 1A-D and Table S2):
Global developmental delay and/or ID (97%); speech disorder
(92.1%); inability to walk (90.1%); spasticity (77.2%); microcephaly
(75.2%); spastic tetraplegia and infantile muscular hypotonia (72.3%);
seizures (71.3%); hyperreflexia (63.4%) and hypertonia (62.4%).
In line with previous studies, which concluded that seizure is a
variable manifestation in AP-4 deficiency syndrome,12,15 28.7% of the
cases described here did not manifest seizures.
Although spastic tetraplegia and spasticity were not reported
in 27.7% and 22.8% of all cases, respectively, hypotonic develop-
mental delay might serve as the initial manifestation of tetraplegia
and spasticity in patients with AP4 variants, as suggested
before.5,6,8,15
Nearly 10% of all cases described here were able to walk in the
time of the report. However, it is probable that this ability will regress
over time because of spasticity and/or foot deformities.5,6,8,15
Dysmorphic facial features were reported in 76 out of 101 cases.
Bulbous nose and wide mouth were the most frequent facial abnor-
malities (42.6%) (Table 1F & Table S1).
In 82 out of 101 cases at least one brain abnormality was
reported. Major characteristic findings in brain MRIs comprised abnor-
mal corpus callosum morphology (63.4%), ventriculomegaly (44.5%),
enlarged cisterns and white matter abnormalities (~30%) (Table 1E &
Tables S1 and S2).
4.2 | Additional clinical findings in AP-4 deficiency
syndrome
There are some extra clinical features manifested at least in 25% of
the patients. These included short stature (51.5%), drooling (40.6%),
low or weak muscle tone (32.7%), talipes equinovarus (39.6%), con-
tractures (48.5%), and Babinski sign (53.5%) (Table S2).
TABLE 1 (Continued)
Phenotype category AP4M1 AP4B1 AP4S1 AP4E1
High palate 33.3 22.7 46.7 0
Hypertelorism 0 2.3 13.3 0
Pointed chin 0 0 20 22.2
Prominent antihelix 9.1 11.4 20 22.2
Downslanted palpebral fissures 0 0 0 0
Abbreviation: AP-4, adaptor protein complex-4.
aNeurodevelopmental abnormality indicates for global developmental delay and intellectual disability; Upper motor neuron dysfunction indicates for spastic
tetraplegia/tetraparesis/paraplegia, hypertonia and spasticity; Abnormal reflex includes hyperreflexia and positive Babinski sign.
bAbnormality of the musculature includes infantile muscular hypotonia, low or weak muscle tone, decreased muscle mass and abnormality of facial muscu-
lature; Abnormality of the limbs includes talipes equinovarus, pes planus and adducted thumb; Joint mobility abnormalities include contractures and joint
laxity.
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In psychiatric behavior, stereotypic laughter was the most com-
mon feature that appeared in 51.5% of the cases.
Table S3 presents other less frequent findings in these patients.
These features might be simply a coincidental findings and not the
straight result of AP-4 deficiency.
4.3 | More heterogeneity in patients harboring
variations in AP-4 complex subunits
In a Moroccan consanguineous family with neurodegeneration associ-
ated with brain iron accumulation, a disease-causing AP4M1 variant
(p.Arg306*) has been reported.16 Like other cases with AP4M1 muta-
tions, the neurological findings were common in these patients. In
addition to ventriculomegaly, thinning of the splenium of the corpus
callosum, cerebral atrophy and white matter loss, they had also mar-
ked bilateral pallidal iron accumulation on brain MRI of their cases
(Tables S1 & 3).16
Also, we included a homozygous AP4S1 variant, c.138
+ 3_6delAAGT, which has been reported in two unrelated families
from Albania and Kosovo with totally three cases (Table S1).17,18
Those differ in some features in terms of facial abnormalities, spastic-
ity, and seizures. Vill et al reported some additional clinical features in
their patient, such as bilateral hypointense signal changes in the
globus pallidus in favor of brain iron or copper accumulation, and
ataxia.18
However, we did not observe any evidence suggestive of brain
iron accumulation in Iranian patients even in the oldest one (32-year).
Moreover, Behne et al in 2020 showed unchanged iron content in the
fibroblasts derived from patients with AP-4 deficiency syndrome,19
which might be indicative of further investigation.
In conclusion, our findings add more evidence to the growing
body of genotype-phenotype data in patients with disease-
causing variants in AP-4 complex subunits. Furthermore, identifi-
cation of disease-causing variants in AP-4 complex subunits in
12 out 640 (~2%) Iranian families with inherited ID, might reflect
the high prevalence of AP-4 Deficiency Syndrome among Iranian
ID patients.
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